Medpace Holdings Raised to Neutral From Sell by UBS
UBS analyst initiated coverage on Medpace Holdings with a Neutral rating and a Sell rating.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.